U87-MG-luc Orthotopic Model

Synonyms: U87-luc

U87-MG-luc is a luminescent glioblastoma cell line derived from U87-MG. It expresses luciferase, allowing for non-invasive monitoring of tumor growth and response to therapies using bioluminescence imaging techniques. U87-MG-luc serves as a valuable model for studying glioblastoma multiforme (GBM) and evaluating therapeutic strategies. Researchers utilize this cell line to investigate GBM biology, test novel treatments, and assess drug efficacy in preclinical studies.

Model Details

Cancer Type: Brain Cancer
Model Name: U87-MG-luc
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temolozide)

U87-MG-luc Survival

Survival of U87-MG-luc after orthotopic intracranial injection in Nu/Nu mice (n=10)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content